Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - United Kingdom
Summary - Nhs Framework Agreement For Branded Medicines - Tranche B - Nofe & Mae And Eculizumab & Ravulizumab For London & Sofe - 01 September 2025
Deadline - Apr 07, 2025
GT reference number - 103492087
Product classification - Pharmaceutical products
Address - United Kingdom
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 103492087
Document Type - Tender Notices
Description - Description: NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines – Tranche B for North of Engla nd and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines – Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026local title:: NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025Contract Type: : Supplyloca
Gt Ref Id - 103492087
Deadline - Apr 07, 2025
View more tenders for
Pharmaceuticals Tenders Pharmaceutical products Tenders United Kingdom TendersSimilar Tenders :
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
